{"retracted":false,"update":{"timestamp":1472688000000,"doi":"10.1136/bmjopen-2016-011371corr1","type":"correction"},"doi":"10.1136/bmjopen-2013-003533","journal":"BMJ Open","publisher":"BMJ","title":"Correction:Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na√Øve women: results from the control arm of a phase II HPV-16/18 vaccine trial"}
